Matches in SemOpenAlex for { <https://semopenalex.org/work/W1508586572> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1508586572 endingPage "7" @default.
- W1508586572 startingPage "4413" @default.
- W1508586572 abstract "The anti-estrogen tamoxifen (TAM) is widely used in the therapy of human breast cancer. Shown to induce a G1 transition delay in vitro, the kinetic effects of TAM on breast carcinoma cells growing as tumor xenografts in nude mice have been less well characterized. In this study, we demonstrate a significant increase in the tumor potential doubling time (Tpot) and decrease in the labeling index (%LI) of estradiol (E2)-stimulated MCF-7 xenografts following TAM treatment or E2 deprivation. MCF-7 tumor pieces were transplanted s.c. into nude mice supplemented with Silastic capsules containing E2. After 2-4 weeks, animals were randomized to continued E2 treatment, E2 and TAM treatment, or E2 deprivation. At times ranging from 0 to 23 days after treatment, animals were given injections of bromodeoxyuridine and tumors excised for kinetic analysis. Using flow-cytometric techniques, the Tpot and %LI were estimated for all tumors. Seven independent experiments were performed and data pooled for statistical analysis. At the time of hormonal manipulation, E2-stimulated tumors had a volume doubling time of 5 days, a Tpot of 2.3 days, and a %LI of 23%. Continued E2 treatment resulted in only minimal changes in Tpot and %LI over the remainder of the observation period. Treatment with TAM resulted in a slowing of tumor growth (tumor doubling time, 12 days), a significant (P < 0.001) increase in Tpot to 6.6 days, and a decrease in %LI to 8% by 23 days posttreatment. E2 deprivation resulted in a cessation of tumor growth and similar changes in Tpot and %LI to 5.3 days and 10%, respectively (P < 0.001). In contrast to previous reports, these data demonstrate that TAM treatment and E2 deprivation both significantly decrease tumor cell proliferation in MCF-7 xenografts." @default.
- W1508586572 created "2016-06-24" @default.
- W1508586572 creator A5001356000 @default.
- W1508586572 creator A5005756055 @default.
- W1508586572 creator A5009332588 @default.
- W1508586572 creator A5015247761 @default.
- W1508586572 creator A5027168289 @default.
- W1508586572 creator A5079412691 @default.
- W1508586572 date "1993-09-15" @default.
- W1508586572 modified "2023-09-23" @default.
- W1508586572 title "Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry." @default.
- W1508586572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8364937" @default.
- W1508586572 hasPublicationYear "1993" @default.
- W1508586572 type Work @default.
- W1508586572 sameAs 1508586572 @default.
- W1508586572 citedByCount "12" @default.
- W1508586572 crossrefType "journal-article" @default.
- W1508586572 hasAuthorship W1508586572A5001356000 @default.
- W1508586572 hasAuthorship W1508586572A5005756055 @default.
- W1508586572 hasAuthorship W1508586572A5009332588 @default.
- W1508586572 hasAuthorship W1508586572A5015247761 @default.
- W1508586572 hasAuthorship W1508586572A5027168289 @default.
- W1508586572 hasAuthorship W1508586572A5079412691 @default.
- W1508586572 hasConcept C121608353 @default.
- W1508586572 hasConcept C126322002 @default.
- W1508586572 hasConcept C134018914 @default.
- W1508586572 hasConcept C185592680 @default.
- W1508586572 hasConcept C202751555 @default.
- W1508586572 hasConcept C203014093 @default.
- W1508586572 hasConcept C204232928 @default.
- W1508586572 hasConcept C2777164284 @default.
- W1508586572 hasConcept C2777176818 @default.
- W1508586572 hasConcept C2778260397 @default.
- W1508586572 hasConcept C48900799 @default.
- W1508586572 hasConcept C530470458 @default.
- W1508586572 hasConcept C553184892 @default.
- W1508586572 hasConcept C55493867 @default.
- W1508586572 hasConcept C71924100 @default.
- W1508586572 hasConceptScore W1508586572C121608353 @default.
- W1508586572 hasConceptScore W1508586572C126322002 @default.
- W1508586572 hasConceptScore W1508586572C134018914 @default.
- W1508586572 hasConceptScore W1508586572C185592680 @default.
- W1508586572 hasConceptScore W1508586572C202751555 @default.
- W1508586572 hasConceptScore W1508586572C203014093 @default.
- W1508586572 hasConceptScore W1508586572C204232928 @default.
- W1508586572 hasConceptScore W1508586572C2777164284 @default.
- W1508586572 hasConceptScore W1508586572C2777176818 @default.
- W1508586572 hasConceptScore W1508586572C2778260397 @default.
- W1508586572 hasConceptScore W1508586572C48900799 @default.
- W1508586572 hasConceptScore W1508586572C530470458 @default.
- W1508586572 hasConceptScore W1508586572C553184892 @default.
- W1508586572 hasConceptScore W1508586572C55493867 @default.
- W1508586572 hasConceptScore W1508586572C71924100 @default.
- W1508586572 hasIssue "18" @default.
- W1508586572 hasLocation W15085865721 @default.
- W1508586572 hasOpenAccess W1508586572 @default.
- W1508586572 hasPrimaryLocation W15085865721 @default.
- W1508586572 hasRelatedWork W1536362773 @default.
- W1508586572 hasRelatedWork W1566586498 @default.
- W1508586572 hasRelatedWork W164721950 @default.
- W1508586572 hasRelatedWork W1992827635 @default.
- W1508586572 hasRelatedWork W2006360026 @default.
- W1508586572 hasRelatedWork W2030305135 @default.
- W1508586572 hasRelatedWork W2387927325 @default.
- W1508586572 hasRelatedWork W2397781633 @default.
- W1508586572 hasRelatedWork W4246551224 @default.
- W1508586572 hasRelatedWork W2025883994 @default.
- W1508586572 hasVolume "53" @default.
- W1508586572 isParatext "false" @default.
- W1508586572 isRetracted "false" @default.
- W1508586572 magId "1508586572" @default.
- W1508586572 workType "article" @default.